JP2023536746A5 - - Google Patents
Info
- Publication number
- JP2023536746A5 JP2023536746A5 JP2023507951A JP2023507951A JP2023536746A5 JP 2023536746 A5 JP2023536746 A5 JP 2023536746A5 JP 2023507951 A JP2023507951 A JP 2023507951A JP 2023507951 A JP2023507951 A JP 2023507951A JP 2023536746 A5 JP2023536746 A5 JP 2023536746A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- peptide according
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026070931A JP2026120788A (ja) | 2020-08-07 | 2026-04-22 | アルツハイマー病の処置のためのタウワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063062971P | 2020-08-07 | 2020-08-07 | |
| US63/062,971 | 2020-08-07 | ||
| PCT/US2021/033189 WO2022031342A1 (en) | 2020-08-07 | 2021-05-19 | Tau vaccine for the treatment of alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026070931A Division JP2026120788A (ja) | 2020-08-07 | 2026-04-22 | アルツハイマー病の処置のためのタウワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536746A JP2023536746A (ja) | 2023-08-29 |
| JP2023536746A5 true JP2023536746A5 (cg-RX-API-DMAC10.html) | 2024-05-28 |
Family
ID=80118379
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507951A Withdrawn JP2023536746A (ja) | 2020-08-07 | 2021-05-19 | アルツハイマー病の処置のためのタウワクチン |
| JP2026070931A Pending JP2026120788A (ja) | 2020-08-07 | 2026-04-22 | アルツハイマー病の処置のためのタウワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026070931A Pending JP2026120788A (ja) | 2020-08-07 | 2026-04-22 | アルツハイマー病の処置のためのタウワクチン |
Country Status (12)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| CN115894659B (zh) * | 2022-10-19 | 2023-11-10 | 上海优宁维生物科技股份有限公司 | 微管相关蛋白Tau抗原及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4218794A3 (en) * | 2009-06-10 | 2023-09-13 | New York University | Immunological targeting of pathological tau proteins |
| CN102596236B (zh) * | 2009-07-30 | 2015-06-24 | 辉瑞疫苗有限责任公司 | 抗原性Tau肽及其用途 |
| EP3275461A1 (en) * | 2011-09-19 | 2018-01-31 | Axon Neuroscience SE | Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease field |
| WO2015098963A1 (ja) * | 2013-12-26 | 2015-07-02 | 東亞合成株式会社 | カルレティキュリンの発現促進方法および該方法に用いられる合成ペプチド |
| WO2015165961A1 (en) * | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
| WO2016154522A1 (en) * | 2015-03-25 | 2016-09-29 | Stc. Unm | Immunotherapy compositions and methods for treatment of tauopathy and transgenic mouse |
| KR20250058066A (ko) * | 2015-07-21 | 2025-04-29 | 화이자 인코포레이티드 | 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도 |
| SG11201910066QA (en) * | 2017-05-02 | 2019-11-28 | Prothena Biosciences Ltd | Antibodies recognizing tau |
| JP2020536946A (ja) * | 2017-10-16 | 2020-12-17 | アジュバンス・テクノロジーズ・インコーポレーテッド | トリテルペンサポニン類似物 |
| WO2020120644A1 (en) * | 2018-12-13 | 2020-06-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New anti tau svqivykpv epitope single domain antibody |
| TWI859197B (zh) * | 2019-03-03 | 2024-10-21 | 愛爾蘭商普羅帝納生物科學公司 | 識別ｔａｕ之抗體 |
-
2021
- 2021-05-19 IL IL300346A patent/IL300346A/en unknown
- 2021-05-19 US US18/020,037 patent/US20230302127A1/en active Pending
- 2021-05-19 WO PCT/US2021/033189 patent/WO2022031342A1/en not_active Ceased
- 2021-05-19 TW TW110118155A patent/TW202221022A/zh unknown
- 2021-05-19 AU AU2021321206A patent/AU2021321206A1/en active Pending
- 2021-05-19 JP JP2023507951A patent/JP2023536746A/ja not_active Withdrawn
- 2021-05-19 MX MX2023001501A patent/MX2023001501A/es unknown
- 2021-05-19 CN CN202180068044.6A patent/CN117751132A/zh active Pending
- 2021-05-19 CA CA3188458A patent/CA3188458A1/en active Pending
- 2021-05-19 EP EP21854646.3A patent/EP4192583A4/en active Pending
- 2021-05-19 KR KR1020237007892A patent/KR20230080398A/ko active Pending
- 2021-05-19 AR ARP210101372A patent/AR122129A1/es unknown
-
2026
- 2026-04-22 JP JP2026070931A patent/JP2026120788A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023526500A5 (cg-RX-API-DMAC10.html) | ||
| JP2023541669A5 (cg-RX-API-DMAC10.html) | ||
| JP2023536995A5 (cg-RX-API-DMAC10.html) | ||
| JP2023541670A5 (cg-RX-API-DMAC10.html) | ||
| JP2011529084A5 (cg-RX-API-DMAC10.html) | ||
| US10596238B2 (en) | Methods and compositions related to immunogenic fibrils | |
| KR20000005429A (ko) | 비수지성 주쇄 펩티드 담체 | |
| US20030175285A1 (en) | Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid | |
| JP2023541671A5 (cg-RX-API-DMAC10.html) | ||
| US11285204B2 (en) | Tobamovirus-based virus-like particles and vaccines | |
| JP2012523379A (ja) | 免疫原性組成物およびその使用 | |
| JP2022514411A (ja) | リポペプチドビルディングブロックおよび合成ウイルス様粒子 | |
| US20230372461A1 (en) | Immunogenic peptides, compositions, and methods for the treatment and/or prevention of malaria | |
| CA2732215A1 (en) | Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies | |
| US20050049197A1 (en) | Induction of immune response against desired determinants | |
| JP3057748B2 (ja) | 細胞毒性ｔリンパ球の特異的誘導用合成ワクチン | |
| AU2016201589B2 (en) | Peptide adjuvants | |
| Gras-Masse | Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations | |
| WO2004011486A2 (fr) | Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une response de type ctl antitumorale ou anti-infectieuse | |
| JP2024538615A5 (cg-RX-API-DMAC10.html) | ||
| CN119894531A (zh) | Tau肽免疫原构建体 | |
| CN118660717A (zh) | 抗α-突触核蛋白的治疗性疫苗 | |
| FR2842812A1 (fr) | Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une reponse de type ctl antitumorale ou anti-infectueuse | |
| KR20080004445A (ko) | 절단형 ｌｈｒｈ 포뮬레이션 | |
| FR2842811A1 (fr) | Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une reponse de type ctl antitumorale ou anti-infectueuse |